Lorlatinib is an active pharmaceutical ingredient used in the manufacture of medications for non-small cell lung cancer. It acts as an inhibitor of anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (ROS1), making it a compound for targeted cancer research and pharmaceutical production.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Lorlatinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Dasabuvir sodium hydrate
pharmaceutical raw material
Paritaprevir dihydrate
pharmaceutical raw material
Cetrotide
pharmaceutical raw material
Phenyl (3R,4R)-4-(3-isopropoxyphenyl)-3,4-dimethylpiperidine-1-carboxylate
pharmaceutical raw material
The international HS code for Lorlatinib (CAS 1454846-35-5) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile
IIXWYSCJSQVBQM-LLVKDONJSA-N
C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C
Sourcing Lorlatinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.